Shengqian Hong

ORCID: 0000-0002-2171-2512
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neonatal Respiratory Health Research
  • Lymphatic System and Diseases
  • Immunotherapy and Immune Responses
  • TGF-β signaling in diseases
  • Melanoma and MAPK Pathways
  • Pancreatic and Hepatic Oncology Research
  • Bone health and treatments
  • Pancreatitis Pathology and Treatment
  • vaccines and immunoinformatics approaches
  • Multiple Myeloma Research and Treatments
  • T-cell and B-cell Immunology
  • Cancer, Lipids, and Metabolism
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Neuroendocrine Tumor Research Advances
  • Ferroptosis and cancer prognosis

Huaian First People’s Hospital
2023

Nanjing Medical University
2023

Xuzhou Medical College
2023

Second People’s Hospital of Huai’an
2023

The University of Texas MD Anderson Cancer Center
2012

Vascular endothelial growth factor (VEGF) is a mediator of airway inflammation and remodelling in asthma. Transforming (TGF)-β 1 plays pivotal roles diverse biological processes, including tissue repair number chronic lung diseases. However, there are few studies elucidating the interactions between VEGF TGF-β allergic disease. A murine model disease was used to define mechanism by which induces subepithelial fibrosis investigate potential relationship mechanisms signalling regulates...

10.1183/09031936.00125007 article EN European Respiratory Journal 2007-12-05

Summary Dendritic cells (DCs) are the most potent antigen-presenting and mediators of T cell immunity. Many investigators have explored potential using DCs as a vaccine for tumour-derived antigens in immunotherapy B malignancies, results been disappointing. To search better tumour to improve efficacy DC-based myeloma, we evaluated compared vaccination pulsed with idiotype (Id) or lysate 5TGM1 myeloma mouse model. Our showed that Id- lysate-pulsed DC vaccines protected mice efficiently...

10.1111/j.1365-2249.2012.04642.x article EN Clinical & Experimental Immunology 2012-07-17

Abstract Aim Microvascular invasion (MVI) is an independent risk factor for postoperative recurrence and metastasis in hepatocellular carcinoma (HCC). However, the specific protein expression profiles that differentiate HCC with MVI from those without remain unclear. Methods The of proteins early‐stage tissues normal liver were characterized by quantitative proteomics techniques. Immunohistochemical (IHC) staining was undertaken on tissue microarrays 80 patients to assess MSH2 MSH6. Cell...

10.1111/hepr.13971 article EN Hepatology Research 2023-09-30
Coming Soon ...